Most dividend stocks pay a pittance these days. The S&P 500's dividend yield is around 1.2%, near its lowest level in over ...

Investment analysts at Raymond James upped their FY2024 earnings per share (EPS) estimates for shares of Profound Medical in a report released on Tuesday, February 18th. Raymond James analyst M.

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond ...

From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Medtronic's stock is probably not a jaw-dropping bargain at these prices, but it's an excellent business at a reasonable value. It's safe to call Medtronic a solid buy, especially if you're a ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2024 investor letter. A ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Globus Medical (GMED – Research Report), Glaukos ...

LONDON (Reuters) - The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for ...